首页> 外国专利> Procedures for selecting anti-CXCR4 antibodies and certain antibodies; nucleic acids for coding antibodies; vectors; Clula HuestPed; production processes; eczema produced by antibodies; compounds; use of selected antibodies I'm here for treatment.

Procedures for selecting anti-CXCR4 antibodies and certain antibodies; nucleic acids for coding antibodies; vectors; Clula HuestPed; production processes; eczema produced by antibodies; compounds; use of selected antibodies I'm here for treatment.

机译:选择抗CXCR4抗体和某些抗体的程序;用于编码抗体的核酸;向量; Clula HuestPed;生产过程;抗体引起的湿疹;化合物;使用所选的抗体我在这里进行治疗。

摘要

The present invention relates to a novel isolated antibody, or the derived compounds or functional fragments of same, capable of binding to CXCR4 but also of inducing conformational changed of the CXCR4 homodimers and/or heterodimers. More particularly, the present invention relates to the 414H5 and 515H7 antibodies, specific to the CXCR4 protein, as well as their use for the treatment of cancer. Pharmaceutical compositions composed of such antibodies and a process for the selection of such antibodies are also covered.
机译:本发明涉及新颖的分离的抗体,或其衍生的化合物或它们的功能片段,其能够结合CXCR4但还能够诱导CXCR4同二聚体和/或异二聚体的构象改变。更具体地,本发明涉及对CXCR4蛋白特异的414H5和515H7抗体,以及它们在治疗癌症中的用途。还涵盖了由此类抗体组成的药物组合物和选择此类抗体的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号